Pharmaceutical Industry discussion, review, analysis, news and information. |
« CTI Filed USFDA SPA for Phase III Trial of XYOTAX™ in Women Lung Cancer | Main | DoD Awarded Grant to Cleveland BioLabs for Development of Radiation Countermeasure Compound, Protectan CBLB502 »
|
Mar25
|
An interventional pain management company, MINRAD International, Inc. (AMEX: BUF) has real time image guidance and anesthesia and analgesia product lines. Sevoflurane is an inhaled general anesthetic. Read the full report. [photo credit: Baxter Sevo] |
TrackBack URL for this entry:
« CTI Filed USFDA SPA for Phase III Trial of XYOTAX™ in Women Lung Cancer | Main | DoD Awarded Grant to Cleveland BioLabs for Development of Radiation Countermeasure Compound, Protectan CBLB502 »
Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!
BIZZlogos - Add your logo - free link to your site| View Network Map Network Feed List (OPML) Know More Media Network Feed |
PharmaGazette is a member of the Know More Media network of business related blogs.
Here are some current headlines from some of our business publications:
ProductivityGoal | CallCenterScript |
AdHurl | TheBizofKnowledge |
LandingTheDeal | CustomersAreAlways |
HealthCareVox | BrainBasedBusiness |
TheInsurancePolicy | MarketingBlurb |
Write for us About us Contact Advertise Privacy Disclaimer
This weblog is licensed under a Creative Commons License.
Comment Preview